Harris Associates, the US investment fund that has been one of Tesco's biggest and most loyal shareholders, has sold almost two thirds of its stake because it thinks the supermarket group has become too risky, the Sunday Telegraph reported. David Herro, Harris's chief executive, said there were too
Read moreBy Sharon Begley NEW YORK, Aug 29 (Reuters) - The experimental Ebola drug ZMapp cured all 18 of the lab monkeys infected with the deadly virus, including those suffering the fever and hemorrhaging characteristic of the disease and just hours from death, scientists reported on Friday.
Read more* Number of cases possibly 2-4 times higher than reported * 12,000 local staff, 750 international experts needed * Nigeria reports spread to main African oil hub * Air service suspension threatens aid operation - WHO (Adds Liberian president) By Stephanie Nebehay and Tim
Read moreBy Julie Steenhuysen CHICAGO, Aug 28 (Reuters) - Genetic studies of some of the earliest Ebola cases in Sierra Leone reveal more than 300 genetic changes in the virus as it leapt from person to person, changes that could blunt the effectiveness of diagnostic tests and experimental treatment
Read more* Number of cases possibly 2-4 times higher than reported * 12,000 local staff, 750 international experts needed * Nigeria reports spread to main African oil hub * Air service suspension threatens aid operation - WHO (Adds details, quotes) By Stephanie Nebehay and Tim Co
Read more(Corrects to show dead doctor did not treat Sawyer) * Number of cases possibly 2-4 times higher than reported * 12,000 local staff, 750 international experts needed * Operation to combat outbreak to cost $490 mln * Nigeria reports possible spread to main African oil hub
Read more* Trials to vaccinate healthy volunteers from mid-September * Planned stockpile of up to 10,000 doses for early use * GSK working with U.S. NIH and international consortium * U.S. researchers also testing Canadian Ebola vaccine (Updates with further details on clinical trial p
Read moreGlaxosmithkline has been given permission to begin testing its Ebola virus vaccine on humans next week. The drugs giant and its partner on the experimental treatment, the US National Institutes of Health's Vaccine Research Centre, have been granted approval by the US Food and Drug Administration to
Read moreLONDON, Aug 28 (Reuters) - An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into human studies and the company plans to build up a stockpile of up to 10,000 doses for emergency deployment, if results are good. Britain's biggest drugmaker said on Thursday the research
Read moreBy Sharon Begley NEW YORK, Aug 27 (Reuters) - U.S. health officials will announce on Thursday that a human study of an Ebola vaccine made by GlaxoSmithKline will begin within a couple of weeks and not later this year as the company estimated originally, according to people familiar with the
Read more